0001209191-22-005453.txt : 20220128 0001209191-22-005453.hdr.sgml : 20220128 20220128170635 ACCESSION NUMBER: 0001209191-22-005453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHREWSBURY STEPHEN B CENTRAL INDEX KEY: 0001413821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 22569875 MAIL ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY STREET 2: SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-26 0 0001445499 IMPEL NEUROPHARMA INC IMPL 0001413821 SHREWSBURY STEPHEN B C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260 SEATTLE WA 98119 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 9.85 2022-01-26 4 A 0 30000 0.00 A 2032-01-25 Common Stock 30000 30000 D The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ John Leaman, M.D. as attorney-in-fact 2022-01-28